Additional examination of brain tissues from AD patients revealed global DNA hypomethylation along with diminished immunoreactivity for DNMT1 and multiple components of the MeCP1/MBD2 methylation complex [63, 64], further supporting a neuroprotective role of DNA methylation in AD etiology. This evidence concerns the gene DNMT1 and Alzheimer disease.